Table 3.
Mean per capita TPE and THE per country by income group in 2010
|
Mean per capita TPE* |
Mean per capita THE |
|||||||
|---|---|---|---|---|---|---|---|---|
| Public expenditure ($) | Private expenditure ($) | Total $ | Public expenditure ($) | Private expenditure ($) | Total $ | % TPE of THE | ||
| High (n=49) | $279·2 (60·9%) | $179·2 (39·1%) | $458·4 | $2203·0 (73·1%) | $811·7 (26·9%) | $3014·7 | 15·2% | |
| Upper-middle (n=53) | $39·6 (37·2%) | $66·7 (62·8%) | $106·3 | $334·4 (63·9%) | $189·0 (36·1%) | $523·4 | 20·3% | |
| Lower-middle (n=48) | $11·9 (32·4%) | $24·8 (67·6%) | $36·7 | $88·9 (60·1%) | $59·1 (39·9%) | $148·0 | 24·8% | |
| Low (n=32) | $2·0 (22·7%) | $6·8 (77·3%) | $8·8 | $13·9 (40·1%) | $20·8 (59·9%) | $34·7 | 25·4% | |
| Total (n=182) | $90·2 (54·3%) | $75·8 (45·7%) | $166·0 | $716·4 (71·0%) | $292·8 (29·0%) | $1009·2 | 16·4% | |
Data are US$, percentages are in parentheses. TPE= total pharmaceutical expenditure. THE=total health expenditure.
*
Essential medicines expenditure is a subcomponent of TPE. The data source does not allow differentiation between expenditure on essential and non-essential medicines. Data from National Health Accounts.